Using neuron cultures derived from fetal mouse central nervous system tissues (17) and frozen sections of rat spinal cords (3), we previously demonstrated the presence of autoantibodies of the immunoglobulin G (IgG) class against axonal neurofilament proteins in the sera of patients with kuru and Creutzfeldt-Jakob disease (CJD) and in the sera of a smaller percentage of patients with other or no neurological disorders (3, 16) . Since these autoantibodies in human sera reacted with neurofilament proteins of neuron cultures prepared from several species of mammalian hosts, they were classified as being heterogeneic (16, 17) .
We now report the occurrence of these heterogeneic autoantibodies in the sera of chimpant Tomonobu Aoki was a visiting fellow from the Department of Microbiology, School of Medicine, Kyushu University, Fukuoka, Japan. zees, Old World and New World monkeys, and laboratory rodents experimentally infected with kuru, CJD, and scrapie, as well as in the sera of sheep naturally infected with scrapie. These autoantibodies occurred in the sera of some normal nonhuman primates before experimental inoculation with the viruses that cause subacute spongiform encephalopathies. In other animals, autoantibodies appeared during the course of disease. The biological and pathogenetic significance of heterogeneic autoantibodies against neurofilament proteins in experimental kuru and CJD and natural scrapie infection remains to be determined. gestation as previously described (17) . Briefly, cells were grown on glass cover slips in Dulbecco modified medium containing 10% fetal bovine serum, 10% horse serum, dextrose (10 g/liter) crystalline insulin (80 U/liter), and NaHCO3 (1.5 g/liter) at 37°C and 10% CO2 atmosphere. Maintenance medium contained 20% horse serum and arabinosylcytosine (10 mg/liter) but did not contain fetal bovine serum. Sera. Before testing, all sera had been stored frozen at -20 to -70°C for periods ranging from several months to several years after collection from animals being maintained for long-term transmission experiments. Pre-and post-inoculation serum specimens from 108 chimpanzees were divided into three groups: (group 1) 41 chimpanzees that developed CJD after inoculation with suspensions of CJD-infected brain tissues from human and animal sources; (group 2) 48 chimpanzees that developed kuru after inoculation with suspensions of kuru-infected brain tissues from human and animal sources; and (group 3) 19 chimpanzees that had been asymptomatic for many (Fig. 1) . Of the eight kuru-infected chimpanzees with autoantibodies in terminal-phase sera, two had autoantibodies before inoculation and throughout the course of the disease, three developed autoantibodies during the asymptomatic phase, and three developed autoantibodies during the terminal clinical phase of the disease (Fig. 2) anti-human IgM (,u-chain). The titers of autoantibodies in the terminal-phase sera ranged from 1:32 to 1:512. There were no significant differences in autoantibody titers among the sera from chimpanzees with CJD and kuru (Fig. 3) or in the rate of occurrence of autoantibodies in the sera of male (12 of 65, 18.5%) and female (8 of 43, 18.6%) chimpanzees during the terminal phase of the disease.
To determine if changes in autoantibody titers occurred during the course of disease, serial serum specimens from four chimpanzees with CJD and four with kuru were tested. In each of the two groups of chimpanzees, two animals had autoantibodies in the pre-inoculation specimens and in the sera collected throughout the course of the disease, and two animals developed autoantibodies during the course of the disease. Once autoantibodies appeared, their titers did not vary significantly during the course of illness in either CJD-infected (Fig. 4a) or kuru-infected animals (Fig. 4b) .
Autoantibodies were detected in the terminalphase sera of 3 of 15 rhesus monkeys with CJD and 2 of 15 African green monkeys with CJD but in neither species infected with kuru or scrapie. terns in indirect immunofluorescence tests with sera from nonhuman primates, a rodent, and a sheep (Fig. 5) were indistinguishable from the pattern obtained with human serum containing autoantibodies to neurofilament proteins and were restricted to the 10-nm filaments in the axonal processes. In contrast, the staining patterns were clearly different from those obtained with rabbit antisera specific for actin, tubulin, and glial fibrillary acidic protein (Fig. 6) . When neuron cultures were stained with highly specific rabbit antiserum prepared against purified neurofilament proteins, the staining pattern was identical to that obtained with the naturally occurring autoantibodies in sera of humans, nonhuman primates, sheep, and a rodent (Fig. 5  and 6 ).
To confirm the observations that the autoantibodies detected were active against the same cytoskeletal structure, regardless of the species of the host from which the sera were collected, and to ascertain if the stained filaments represented neurofilaments, the double-immunofluorescence staining technique with FITC and rhodamine conjugates was used. As shown in Fig.  7 , no differences were noted in the doublestaining patterns when autoantibody-positive sera and rabbit antiserum to neurofilament proteins were compared: al and a2, positive human serum with positive guinea pig serum; bl and b2, rabbit antiserum to neurofilament proteins with positive nonhuman primate serum. sheep naturally infected with scrapie also had such autoantibodies. When autoantibody titers of the sera from humans with kuru or CJD (16) and from sheep naturally infected with scrapie are compared with those of the sera from experimentally infected animals, it appears that the natural infections with the subacute spongiform virus encephalopathies are associated with higher titers of autoantibodies.
DISCUSSION
Autoantibodies against neurofilament proteins have been demonstrated by immunofluorescence and immunoperoxidase staining techniques in the sera of 59% of CJD patients and 27% of kuru patients (16) . Recently, autoantibodies have also been found in the sera of 11.2% of patients with other neurological diseases and in the sera from normal controls (8%) (C. J. Gibbs, Jr., J. Sotelo, T. Aoki, M. Wurth, and D. C. Gajdusek, manuscript in preparation). These findings have been subsequently confirmed with immunofluorescence-stained longitudinal sections of frozen rat spinal cords (3 (20) , and antimicrotubule antibodies have been reported in infectious mononucleosis (21) . Interactions occurring between viruses and cytoskeletal components include the alteration of actin-containing filaments by Newcastle disease virus and vesicular stomatitis virus (14) , the association of adenoviruses with microtubules (4), the interaction of early adenovirus protein with the cytoskeletal lattice (11) , and the association of budding viruses with microfilaments (15) .
All cytoskeletal filaments, composed principally of microfilaments, intermediate filaments, and microtubules, are normally confined to the cytoplasm and to the inner surfaces of the cell membranes. Recently, actin and tubulin were demonstrated not only on the surfaces of lymphocytes, but also in the growth medium of lymphocyte cultures after mitogenic stimulation, Epstein-Barr virus infection, and malignant transformation, suggesting that cytoskeletal proteins may act as autoantigens in certain viral infections (2) . Viruses, then, might induce autoantibodies by lysing or activating subpopulations of lymphocytes (8) . The recent observation of infection of splenic lymphocytes with the virus that causes CJD (Y. Kuroda, C. J. Gibbs, Jr., H. L. Amyx, and D. C. Gajdusek, manuscript in preparation) suggests such a mechansim for the appearance of autoantibodies in the subacute spongiform encephalopathies.
Alternatively, latent, persistent, or intercurrent infections with conventional viruses (13) may account for autoantibody production. This would explain the finding of autoantibodies against neurofilament proteins in the sera of normal animals and humans. Autoantibodies against intermediate filaments (7, 12, 22) and tubulin (10) have also been detected in the sera of normal preimmunized laboratory animals.
Anti-neurofilament protein autoantibodies previously reported in human sera (16) and now demonstrated in the sera of naturally and experimentally infected animals constitute the first convincing evidence of involvement of the immunological system in the subacute spongiform encephalopathies, in which humoral response was previously unknown (6) . Although the overall incidence of autoantibodies in experimentally infected animals is fairly low and although they do not appear to be specific for these diseases, they may provide a clue in studying the pathogenesis of CJD, kuru, and scrapie. Ultrastructural and biochemical studies of neurofilament alterations in subacute spongiform encephalopathies are already underway.
